Hepatitis due to erythromycin ethylsuccinate
Funck-Brentano, C.; Danan, G.; Pessayre, D.; Benhamou, J.P.
Gastroenterologie Clinique et Biologique 6(12): 1044-1045
1982
ISSN/ISBN: 0399-8320 PMID: 6984402 Document Number: 184551
Document emailed within 1 workday
Related Documents
Bertrand, A.; Jonquet, O.; Sauvaget, J. 1988: Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections Pathologie-Biologie 36(5): 544-547Pessayre, D.; Marie, C.; Benhamou, J.P. 1976: Hepatitis due to erythromycin propionate Archives Francaises des Maladies de l'Appareil Digestif 65(5): 405-408
Ponsot, P.; Théodore, C.; Larrey, D.; Breil, P.; Hugentobler, J.P.; Paolaggi, J.A. 1982: Acute hepatitis caused by erythromycin propionate Gastroenterologie Clinique et Biologique 6(6-7): 594
Gafter, U.; Mandel, E.M.; Weiss, S.; Djaldetti, M. 1979: Erythromycin estolate-induced hepatitis. Ultrastructural study of liver New York State Journal of Medicine 79(1): 87-89
Majer, J.; Stanaszek, R.S.; Mueller, S.L.; Marti, G. 1978: N-Didemethyl-n-propionyl-6,9;9, 12-erythromycin A-spiroketal, a new metabolite of erythromycin ethyl succinate in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(6): 673-676
Klita, S.; Szafranśki, P. 1980: Comparison of the mechanism of action of cyclic 11,12-erythromycin a carbonate and erythromycin a Acta Biochimica Polonica 27(3-4): 213-220
Colombo, N.; Depaoli, A.; Gobetti, M.; Saorin, M.G. 1994: Analytical-physical profile of the novel macrolide antibiotic flurithromycin ethylsuccinate Arzneimittel-Forschung 44(7): 850-855
Murphy, P.J.; Williams, T.L.; McMahon, R.E.; Marshall, F.J. 1975: Metabolism of propionyl erythromycin lauryl sulfate. I. Fate of the propionyl erythromycin moiety in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 3(3): 155-163
Dölle, W. 1979: Erythromycin Deutsche Medizinische Wochenschrift 104(38): 1330
Kjaeldgaard, P.; Friis, H.; Colding, H. 1984: Erythromycin Ugeskrift for Laeger 146(40): 3050-3051
Ari, A. 1977: Epidemiology of viral hepatitis: hepatitis A, hepatitis B and unclassified hepatitis Turk Hijiyen Ve Deneysel Biyoloji Dergisi. Turkish Bulletin of Hygiene and Experimental Biology 37(1): 71-86
Stevens, C.E.; Taylor, P.E.; Tong, M.J.; Toy, P.T.; Vyas, G.N.; Nair, P.V.; Weissman, J.Y.; Krugman, S. 1987: Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257(19): 2612-2616
El-Sayed, N.M.; el-Halawani, T.A. 1995: Comparative study of serum and salivary hepatitis B surface antigen and hepatitis C antibodies among patients infected with hepatitis B or C virus Egyptian Dental Journal 41(3): 1305-1312
Kondo, M.; Sueta, S.; Oida, E.; Tagawa, M. 2015: A case report of hepatitis B virus reactivation in a hepatitis B core antibody-positive, hepatitis B surface antigen-negative hemodialysis patient Nihon Jinzo Gakkai Shi 57(8): 1363-1368
Bonnetblanc, J.M.; Souyri, N.; Bernard, P. 1983: Pemphigoid and erythromycin Annales de Dermatologie et de Venereologie 110(11): 951
Miller, S.M. 1982: Erythromycin ototoxicity Medical Journal of Australia 2(5): 242-243
Grym, J. 1991: Administration of erythromycin Ceskoslovenska Pediatrie 46(5): 306-307
Shishkov, N.; Dilov, P.; Doneva, M. 1977: Use of erythromycin lactate on poultry Veterinarno-Meditsinski Nauki 14(8): 29-38
Bass, J.W. 1983: Use of erythromycin in pertussis outbreaks Pediatrics 72(5): 748-749
Dombrower, P. 1979: Intravenous erythromycin dosages American Journal of Hospital Pharmacy 36(12): 1654